Cannabidiol (Catalan Wikipedia)

Analysis of information sources in references of the Wikipedia article "Cannabidiol" in Catalan language version.

refsWebsite

Global rank Catalan rank

31nih.gov

4^th place

7^th place

27doi.org

2^nd place

6^th place

6web.archive.org

1^st place

4worldcat.org

5^th place

3fda.gov

447^th place

656^th place

2europa.eu

68^th place

49^th place

1figshare.com

5,893^rd place

low place

1harvard.edu

18^th place

40^th place

1sciencenews.org

3,410^th place

2,654^th place

1nihr.ac.uk

low place

1sciencebasedmedicine.org

5,063^rd place

low place

1frontiersin.org

4,679^th place

1,548^th place

doi.org

dx.doi.org

«Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders». Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences, vol. 367, 1607, December 2012, pàg. 3364–3378. DOI: 10.1098/rstb.2011.0389. PMC: 3481531. PMID: 23108553.
«A scoping review of the use of cannabidiol in psychiatric disorders». Psychiatry Research, vol. 308, February 2022, pàg. 114347. DOI: 10.1016/j.psychres.2021.114347. PMC: 8799523. PMID: 34952255.
«Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis». The Lancet. Psychiatry, vol. 6, 12, December 2019, pàg. 995–1010. DOI: 10.1016/S2215-0366(19)30401-8. PMC: 6949116. PMID: 31672337.
«Clinicians' Guide to Cannabidiol and Hemp Oils». Mayo Clinic Proceedings, vol. 94, 9, September 2019, pàg. 1840–1851. DOI: 10.1016/j.mayocp.2019.01.003. PMID: 31447137.
«Cannabidiol as an Intervention for Addictive Behaviors: A Systematic Review of the Evidence». Substance Abuse, vol. 9, January 2015, pàg. 33–38. DOI: 10.4137/SART.S25081. PMC: 4444130. PMID: 26056464.
«Prolonged oral transmucosal delivery of highly lipophilic drug cannabidiol». International Journal of Pharmaceutics, vol. 581, May 2020, pàg. 119276. DOI: 10.1016/j.ijpharm.2020.119276. PMID: 32243971.
«A meta-opinion: cannabinoids delivered to oral mucosa by a spray for systemic absorption are rather ingested into gastro-intestinal tract: the influences of fed / fasting states». Expert Opinion on Drug Delivery, vol. 16, 10, October 2019, pàg. 1031–1035. DOI: 10.1080/17425247.2019.1653852. PMID: 31393180.
«Cannabidiol: State of the art and new challenges for therapeutic applications». Pharmacology & Therapeutics, vol. 175, July 2017, pàg. 133–150. DOI: 10.1016/j.pharmthera.2017.02.041. PMID: 28232276.
«A systematic review of the antipsychotic properties of cannabidiol in humans». Schizophrenia Research, vol. 162, 1–3, March 2015, pàg. 153–161. DOI: 10.1016/j.schres.2015.01.033. PMID: 25667194.
«Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Δ⁹-Tetrahydrocannabinol». Neuropsychopharmacology, vol. 43, 1, January 2018, pàg. 142–154. DOI: 10.1038/npp.2017.209. PMC: 5719112. PMID: 28875990.
«Evolution of the Cannabinoid and Terpene Content during the Growth of Cannabis sativa Plants from Different Chemotypes». Journal of Natural Products, vol. 79, 2, February 2016, pàg. 324–331. DOI: 10.1021/acs.jnatprod.5b00949. PMID: 26836472.
«CBD, a precursor of THC in e-cigarettes». Scientific Reports, vol. 11, 1, April 2021, pàg. 8951. Bibcode: 2021NatSR..11.8951C. DOI: 10.1038/s41598-021-88389-z. PMC: 8076212. PMID: 33903673.
«Cannabidiol as an Intervention for Addictive Behaviors: A Systematic Review of the Evidence». Substance Abuse, vol. 9, 2015, pàg. 33–38. DOI: 10.4137/SART.S25081. PMC: 4444130. PMID: 26056464.
«How effective and safe is medical cannabis as a treatment of mental disorders? A systematic review». European Archives of Psychiatry and Clinical Neuroscience, vol. 269, 1, February 2019, pàg. 87–105. DOI: 10.1007/s00406-019-00984-4. PMC: 6595000. PMID: 30706168.
«Evidence for cannabis and cannabinoids for epilepsy: a systematic review of controlled and observational evidence». Journal of Neurology, Neurosurgery, and Psychiatry, vol. 89, 7, July 2018, pàg. 741–753. DOI: 10.1136/jnnp-2017-317168. PMID: 29511052.
«Cannabis-based products for pediatric epilepsy: An updated systematic review». Seizure, vol. 75, February 2020, pàg. 18–22. DOI: 10.1016/j.seizure.2019.12.006. PMID: 31865133.
«Cannabis derivative may reduce seizures in some severe drug-resistant epilepsies, but adverse events increase». NIHR Evidence, 26-06-2018. DOI: 10.3310/signal-000606.
«Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders». Epilepsia, vol. 55, 6, June 2014, pàg. 791–802. DOI: 10.1111/epi.12631. PMC: 4707667. PMID: 24854329.
«Cannabidiol as a Potential Treatment for Anxiety Disorders». Neurotherapeutics, vol. 12, 4, October 2015, pàg. 825–836. DOI: 10.1007/s13311-015-0387-1. PMC: 4604171. PMID: 26341731.
«Efficacy, Safety, and Regulation of Cannabidiol on Chronic Pain: A Systematic Review». Cureus, vol. 14, 7, July 2022, pàg. e26913. DOI: 10.7759/cureus.26913. PMC: 9288157. PMID: 35860716.
«Safety and Toxicology of Cannabinoids». Neurotherapeutics, vol. 12, 4, October 2015, pàg. 735–746. DOI: 10.1007/s13311-015-0380-8. PMC: 4604177. PMID: 26269228.
«Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb». Trends in Pharmacological Sciences, vol. 30, 10, October 2009, pàg. 515–527. DOI: 10.1016/j.tips.2009.07.006. PMID: 19729208.
Oláh, Attila; Tóth, Balázs I.; Borbíró, István; Sugawara, Koji; Szöllõsi, Attila G. «Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes». The Journal of Clinical Investigation, 124, 9, 2014-09, pàg. 3713–3724. DOI: 10.1172/JCI64628. ISSN: 1558-8238. PMC: 4151231. PMID: 25061872.
Palmieri, B.; Laurino, C.; Vadalà, M. «A therapeutic effect of cbd-enriched ointment in inflammatory skin diseases and cutaneous scars». La Clinica Terapeutica, 170, 2, 2019, pàg. e93–e99. DOI: 10.7417/CT.2019.2116. ISSN: 1972-6007. PMID: 30993303.
Petrosino, Stefania; Verde, Roberta; Vaia, Massimo; Allarà, Marco; Iuvone, Teresa «Anti-inflammatory Properties of Cannabidiol, a Nonpsychotropic Cannabinoid, in Experimental Allergic Contact Dermatitis». The Journal of Pharmacology and Experimental Therapeutics, 365, 3, 2018-06, pàg. 652–663. DOI: 10.1124/jpet.117.244368. ISSN: 1521-0103. PMID: 29632236.
Pamplona, Fabricio A.; da Silva, Lorenzo Rolim; Coan, Ana Carolina «Potential Clinical Benefits of CBD-Rich Cannabis Extracts Over Purified CBD in Treatment-Resistant Epilepsy: Observational Data Meta-analysis». Frontiers in Neurology, 9, 12-09-2018, pàg. 759. DOI: 10.3389/fneur.2018.00759. ISSN: 1664-2295. PMC: PMC6143706. PMID: 30258398.
«The Effects of Cannabidiol, a Non-Intoxicating Compound of Cannabis, on the Cardiovascular System in Health and Disease». International Journal of Molecular Sciences, vol. 21, 18, September 2020, pàg. 6740. DOI: 10.3390/ijms21186740. PMC: 7554803. PMID: 32937917.

europa.eu

ema.europa.eu

«Epidyolex EPAR». European Medicines Agency (EMA), 24-06-2019. Arxivat de l'original el August 9, 2021. [Consulta: 11 setembre 2020]. Text was copied from this source which is copyrighted by the European Medicines Agency. Reproduction is authorized provided the source is acknowledged.

ec.europa.eu

«CosIng - Cosmetics - GROWTH - European Commission». [Consulta: 1r març 2023].

fda.gov

Office of the Commissioner. «FDA Approves New Indication for Drug Containing an Active Ingredient Derived from Cannabis to Treat Seizures in Rare Genetic Disease» (en anglès). FDA, 31-07-2020. Arxivat de l'original el September 29, 2021. [Consulta: 25 novembre 2020].
Office of the Commissioner. «FDA Approves First Drug Comprised of an Active Ingredient Derived from Marijuana to Treat Rare, Severe Forms of Epilepsy» (en anglès). FDA, 27-03-2020. Arxivat de l'original el April 23, 2019. [Consulta: 28 maig 2021].
«What You Should Know About Using Cannabis, Including CBD, When Pregnant or Breastfeeding». US Food and Drug Administration (FDA), October 16, 2019. Arxivat de l'original el October 17, 2019. [Consulta: October 17, 2019].

figshare.com

«Evolution of the Cannabinoid and Terpene Content during the Growth of Cannabis sativa Plants from Different Chemotypes». Journal of Natural Products, vol. 79, 2, February 2016, pàg. 324–331. DOI: 10.1021/acs.jnatprod.5b00949. PMID: 26836472.

frontiersin.org

Pamplona, Fabricio A.; da Silva, Lorenzo Rolim; Coan, Ana Carolina «Potential Clinical Benefits of CBD-Rich Cannabis Extracts Over Purified CBD in Treatment-Resistant Epilepsy: Observational Data Meta-analysis». Frontiers in Neurology, 9, 12-09-2018, pàg. 759. DOI: 10.3389/fneur.2018.00759. ISSN: 1664-2295. PMC: PMC6143706. PMID: 30258398.

harvard.edu

adsabs.harvard.edu

«CBD, a precursor of THC in e-cigarettes». Scientific Reports, vol. 11, 1, April 2021, pàg. 8951. Bibcode: 2021NatSR..11.8951C. DOI: 10.1038/s41598-021-88389-z. PMC: 8076212. PMID: 33903673.

nih.gov

ncbi.nlm.nih.gov

«Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders». Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences, vol. 367, 1607, December 2012, pàg. 3364–3378. DOI: 10.1098/rstb.2011.0389. PMC: 3481531. PMID: 23108553.
«A scoping review of the use of cannabidiol in psychiatric disorders». Psychiatry Research, vol. 308, February 2022, pàg. 114347. DOI: 10.1016/j.psychres.2021.114347. PMC: 8799523. PMID: 34952255.
«Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis». The Lancet. Psychiatry, vol. 6, 12, December 2019, pàg. 995–1010. DOI: 10.1016/S2215-0366(19)30401-8. PMC: 6949116. PMID: 31672337.
«Clinicians' Guide to Cannabidiol and Hemp Oils». Mayo Clinic Proceedings, vol. 94, 9, September 2019, pàg. 1840–1851. DOI: 10.1016/j.mayocp.2019.01.003. PMID: 31447137.
«Cannabidiol as an Intervention for Addictive Behaviors: A Systematic Review of the Evidence». Substance Abuse, vol. 9, January 2015, pàg. 33–38. DOI: 10.4137/SART.S25081. PMC: 4444130. PMID: 26056464.
«Prolonged oral transmucosal delivery of highly lipophilic drug cannabidiol». International Journal of Pharmaceutics, vol. 581, May 2020, pàg. 119276. DOI: 10.1016/j.ijpharm.2020.119276. PMID: 32243971.
«A meta-opinion: cannabinoids delivered to oral mucosa by a spray for systemic absorption are rather ingested into gastro-intestinal tract: the influences of fed / fasting states». Expert Opinion on Drug Delivery, vol. 16, 10, October 2019, pàg. 1031–1035. DOI: 10.1080/17425247.2019.1653852. PMID: 31393180.
«Cannabidiol: State of the art and new challenges for therapeutic applications». Pharmacology & Therapeutics, vol. 175, July 2017, pàg. 133–150. DOI: 10.1016/j.pharmthera.2017.02.041. PMID: 28232276.
«A systematic review of the antipsychotic properties of cannabidiol in humans». Schizophrenia Research, vol. 162, 1–3, March 2015, pàg. 153–161. DOI: 10.1016/j.schres.2015.01.033. PMID: 25667194.
«Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Δ⁹-Tetrahydrocannabinol». Neuropsychopharmacology, vol. 43, 1, January 2018, pàg. 142–154. DOI: 10.1038/npp.2017.209. PMC: 5719112. PMID: 28875990.
«Evolution of the Cannabinoid and Terpene Content during the Growth of Cannabis sativa Plants from Different Chemotypes». Journal of Natural Products, vol. 79, 2, February 2016, pàg. 324–331. DOI: 10.1021/acs.jnatprod.5b00949. PMID: 26836472.
«CBD, a precursor of THC in e-cigarettes». Scientific Reports, vol. 11, 1, April 2021, pàg. 8951. Bibcode: 2021NatSR..11.8951C. DOI: 10.1038/s41598-021-88389-z. PMC: 8076212. PMID: 33903673.
«Cannabidiol as an Intervention for Addictive Behaviors: A Systematic Review of the Evidence». Substance Abuse, vol. 9, 2015, pàg. 33–38. DOI: 10.4137/SART.S25081. PMC: 4444130. PMID: 26056464.
«How effective and safe is medical cannabis as a treatment of mental disorders? A systematic review». European Archives of Psychiatry and Clinical Neuroscience, vol. 269, 1, February 2019, pàg. 87–105. DOI: 10.1007/s00406-019-00984-4. PMC: 6595000. PMID: 30706168.
«Evidence for cannabis and cannabinoids for epilepsy: a systematic review of controlled and observational evidence». Journal of Neurology, Neurosurgery, and Psychiatry, vol. 89, 7, July 2018, pàg. 741–753. DOI: 10.1136/jnnp-2017-317168. PMID: 29511052.
«Cannabis-based products for pediatric epilepsy: An updated systematic review». Seizure, vol. 75, February 2020, pàg. 18–22. DOI: 10.1016/j.seizure.2019.12.006. PMID: 31865133.
«Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders». Epilepsia, vol. 55, 6, June 2014, pàg. 791–802. DOI: 10.1111/epi.12631. PMC: 4707667. PMID: 24854329.
«The relationship between cannabidiol and psychosis: A review». Annals of Clinical Psychiatry, vol. 27, 2, May 2015, pàg. 134–141. PMID: 25954940.
«Cannabidiol as a Potential Treatment for Anxiety Disorders». Neurotherapeutics, vol. 12, 4, October 2015, pàg. 825–836. DOI: 10.1007/s13311-015-0387-1. PMC: 4604171. PMID: 26341731.
«Efficacy, Safety, and Regulation of Cannabidiol on Chronic Pain: A Systematic Review». Cureus, vol. 14, 7, July 2022, pàg. e26913. DOI: 10.7759/cureus.26913. PMC: 9288157. PMID: 35860716.
«Safety and Toxicology of Cannabinoids». Neurotherapeutics, vol. 12, 4, October 2015, pàg. 735–746. DOI: 10.1007/s13311-015-0380-8. PMC: 4604177. PMID: 26269228.
«Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb». Trends in Pharmacological Sciences, vol. 30, 10, October 2009, pàg. 515–527. DOI: 10.1016/j.tips.2009.07.006. PMID: 19729208.
Oláh, Attila; Tóth, Balázs I.; Borbíró, István; Sugawara, Koji; Szöllõsi, Attila G. «Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes». The Journal of Clinical Investigation, 124, 9, 2014-09, pàg. 3713–3724. DOI: 10.1172/JCI64628. ISSN: 1558-8238. PMC: 4151231. PMID: 25061872.
Palmieri, B.; Laurino, C.; Vadalà, M. «A therapeutic effect of cbd-enriched ointment in inflammatory skin diseases and cutaneous scars». La Clinica Terapeutica, 170, 2, 2019, pàg. e93–e99. DOI: 10.7417/CT.2019.2116. ISSN: 1972-6007. PMID: 30993303.
Petrosino, Stefania; Verde, Roberta; Vaia, Massimo; Allarà, Marco; Iuvone, Teresa «Anti-inflammatory Properties of Cannabidiol, a Nonpsychotropic Cannabinoid, in Experimental Allergic Contact Dermatitis». The Journal of Pharmacology and Experimental Therapeutics, 365, 3, 2018-06, pàg. 652–663. DOI: 10.1124/jpet.117.244368. ISSN: 1521-0103. PMID: 29632236.
Pamplona, Fabricio A.; da Silva, Lorenzo Rolim; Coan, Ana Carolina «Potential Clinical Benefits of CBD-Rich Cannabis Extracts Over Purified CBD in Treatment-Resistant Epilepsy: Observational Data Meta-analysis». Frontiers in Neurology, 9, 12-09-2018, pàg. 759. DOI: 10.3389/fneur.2018.00759. ISSN: 1664-2295. PMC: PMC6143706. PMID: 30258398.
«The Effects of Cannabidiol, a Non-Intoxicating Compound of Cannabis, on the Cardiovascular System in Health and Disease». International Journal of Molecular Sciences, vol. 21, 18, September 2020, pàg. 6740. DOI: 10.3390/ijms21186740. PMC: 7554803. PMID: 32937917.

pubmed.ncbi.nlm.nih.gov

Oláh, Attila; Tóth, Balázs I.; Borbíró, István; Sugawara, Koji; Szöllõsi, Attila G. «Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes». The Journal of Clinical Investigation, 124, 9, 2014-09, pàg. 3713–3724. DOI: 10.1172/JCI64628. ISSN: 1558-8238. PMC: 4151231. PMID: 25061872.
Palmieri, B.; Laurino, C.; Vadalà, M. «A therapeutic effect of cbd-enriched ointment in inflammatory skin diseases and cutaneous scars». La Clinica Terapeutica, 170, 2, 2019, pàg. e93–e99. DOI: 10.7417/CT.2019.2116. ISSN: 1972-6007. PMID: 30993303.
Petrosino, Stefania; Verde, Roberta; Vaia, Massimo; Allarà, Marco; Iuvone, Teresa «Anti-inflammatory Properties of Cannabidiol, a Nonpsychotropic Cannabinoid, in Experimental Allergic Contact Dermatitis». The Journal of Pharmacology and Experimental Therapeutics, 365, 3, 2018-06, pàg. 652–663. DOI: 10.1124/jpet.117.244368. ISSN: 1521-0103. PMID: 29632236.

dailymed.nlm.nih.gov

«Epidiolex – cannabidiol solution». DailyMed, 26-08-2020. Arxivat de l'original el February 25, 2021. [Consulta: 11 setembre 2020].

nihr.ac.uk

evidence.nihr.ac.uk

«Cannabis derivative may reduce seizures in some severe drug-resistant epilepsies, but adverse events increase». NIHR Evidence, 26-06-2018. DOI: 10.3310/signal-000606.

sciencebasedmedicine.org

«Where Are We With CBD?». Science-Based Medicine, 30-09-2020. Arxivat de l'original el August 12, 2021. [Consulta: October 1, 2020].

sciencenews.org

«The CBD boom is way ahead of the science». Science News, March 27, 2019.

web.archive.org

«Epidiolex – cannabidiol solution». DailyMed, 26-08-2020. Arxivat de l'original el February 25, 2021. [Consulta: 11 setembre 2020].
Office of the Commissioner. «FDA Approves New Indication for Drug Containing an Active Ingredient Derived from Cannabis to Treat Seizures in Rare Genetic Disease» (en anglès). FDA, 31-07-2020. Arxivat de l'original el September 29, 2021. [Consulta: 25 novembre 2020].
«Epidyolex EPAR». European Medicines Agency (EMA), 24-06-2019. Arxivat de l'original el August 9, 2021. [Consulta: 11 setembre 2020]. Text was copied from this source which is copyrighted by the European Medicines Agency. Reproduction is authorized provided the source is acknowledged.
Office of the Commissioner. «FDA Approves First Drug Comprised of an Active Ingredient Derived from Marijuana to Treat Rare, Severe Forms of Epilepsy» (en anglès). FDA, 27-03-2020. Arxivat de l'original el April 23, 2019. [Consulta: 28 maig 2021].
«Where Are We With CBD?». Science-Based Medicine, 30-09-2020. Arxivat de l'original el August 12, 2021. [Consulta: October 1, 2020].
«What You Should Know About Using Cannabis, Including CBD, When Pregnant or Breastfeeding». US Food and Drug Administration (FDA), October 16, 2019. Arxivat de l'original el October 17, 2019. [Consulta: October 17, 2019].

worldcat.org

Oláh, Attila; Tóth, Balázs I.; Borbíró, István; Sugawara, Koji; Szöllõsi, Attila G. «Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes». The Journal of Clinical Investigation, 124, 9, 2014-09, pàg. 3713–3724. DOI: 10.1172/JCI64628. ISSN: 1558-8238. PMC: 4151231. PMID: 25061872.
Palmieri, B.; Laurino, C.; Vadalà, M. «A therapeutic effect of cbd-enriched ointment in inflammatory skin diseases and cutaneous scars». La Clinica Terapeutica, 170, 2, 2019, pàg. e93–e99. DOI: 10.7417/CT.2019.2116. ISSN: 1972-6007. PMID: 30993303.
Petrosino, Stefania; Verde, Roberta; Vaia, Massimo; Allarà, Marco; Iuvone, Teresa «Anti-inflammatory Properties of Cannabidiol, a Nonpsychotropic Cannabinoid, in Experimental Allergic Contact Dermatitis». The Journal of Pharmacology and Experimental Therapeutics, 365, 3, 2018-06, pàg. 652–663. DOI: 10.1124/jpet.117.244368. ISSN: 1521-0103. PMID: 29632236.
Pamplona, Fabricio A.; da Silva, Lorenzo Rolim; Coan, Ana Carolina «Potential Clinical Benefits of CBD-Rich Cannabis Extracts Over Purified CBD in Treatment-Resistant Epilepsy: Observational Data Meta-analysis». Frontiers in Neurology, 9, 12-09-2018, pàg. 759. DOI: 10.3389/fneur.2018.00759. ISSN: 1664-2295. PMC: PMC6143706. PMID: 30258398.